HCLTECH.NS INR 1328.60 (-2.17%) on NSE 16 Mar 2026: AI strength may revive trend

HCL Technologies Limited (HCLTECH.NS) closed at INR 1328.60 on the NSE on 16 Mar 2026, down -2.17% from the prior close. HCLTECH.NS stock traded 3,618,437.00 shares today as investors digested weak near-term momentum and looked for traction in the company’s AI and DRYiCE software offerings. The stock sits below its 50-day and 200-day averages, which keeps short-term pressure on price but preserves a longer-term recovery case tied to AI demand.

HCLTECH.NS stock: Market close snapshot and price action

HCL Technologies (HCLTECH.NS) ended the session at INR 1328.60, down -29.50 points or -2.17% from INR 1358.10 previous close. Intraday range was INR 1302.40 to INR 1337.70, with volume 3,618,437.00 against an average volume of 2,887,835.00. Year high and low read INR 1780.10 and INR 1302.75 respectively, showing current price sits near the 52-week low.

HCLTECH.NS stock: Fundamentals and valuation

HCL Technologies shows EPS INR 60.63 and a trailing PE of 21.86, with market cap INR 3586071749278.00. Key ratios include P/S 2.83, P/B 4.92, free cash flow yield 5.97%, and dividend per share INR 54.00. Return on equity is 23.23% and debt to equity stands at 0.10, supporting a solid balance sheet despite a stretched price-to-book level.

HCLTECH.NS stock: AI segment, products and growth drivers

HCL Technologies offers DRYiCE, Actian Avalanche and cloud-native services that target enterprise AI transformation. Recent traction in AI services and platform deals is the core growth driver for HCLTECH.NS stock and could lift revenue per share above current trends. Management cites continued demand across financial services and manufacturing, which matches sector appetite for AI-led transformation.

HCLTECH.NS stock: Technical set-up and trading signals

Technicals show RSI 29.35 (oversold) and ADX 42.32 indicating a strong downtrend. The stock trades below its 50-day average INR 1551.80 and 200-day average INR 1558.57, while Bollinger lower band sits at INR 1303.48. Short-term buyers may watch MACD histogram turning positive and a break above INR 1400.51 to confirm momentum recovery.

HCLTECH.NS stock: Meyka AI grade and analyst model forecast

Meyka AI rates HCLTECH.NS with a score out of 100: 80.17 (Grade A, BUY). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst consensus. Meyka AI’s forecast model projects a quarterly price of INR 1330.72 and a yearly target of INR 1930.22, implying a medium-term upside from current price if AI demand materialises.

HCLTECH.NS stock: Risks, valuation gaps and investment view

Key risks for HCL Technologies include slower-than-expected AI deal conversion and margin pressure from wage inflation. Valuation gaps exist versus peers with sector average PE near 31.12, keeping HCLTECH.NS stock valuation relatively attractive on a PEG-adjusted basis. Investors should weigh near-term volatility against a multi-quarter recovery tied to platform monetisation.

Final Thoughts

HCL Technologies (HCLTECH.NS) closed the market on 16 Mar 2026 at INR 1328.60, down -2.17%, leaving the stock below its 50-day and 200-day averages. The immediate technical read is bearish, but the company’s AI and platform products offer a clear path to re-rate the stock if deal pipelines convert. Meyka AI’s model projects a yearly target of INR 1930.22, an implied upside of 45.44% from the current price of INR 1328.60, while the quarterly projection of INR 1330.72 is essentially flat. These forecasts are model-based projections and not guarantees. Use the next earnings release on 21 Apr 2026 as a catalyst read for AI revenue cadence, and consult Meyka AI, our AI-powered market analysis platform, for real-time updates on HCLTECH.NS stock and sector flows.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.